| Participants (N = 255) | 6. Total Dispensation s(n = 1188) | 7. ATC: Nervous system (n = 894) | 8. ATC: Anti-infectives (n = 103) | 9. ATC: Alimentary & Metabolic (n = 64) | ||||
---|---|---|---|---|---|---|---|---|---|
n (%) | n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | |
Post-release OAT use | Â | Â | Â | Â | Â | Â | Â | Â | Â |
None | 148 (58) | 548 (46) | REF | 338 (38) | REF | 79 (77) | REF | 41 (64) | – |
Interrupted | 32 (13) | 155 (13) | 1.88 (1.19–2.98) | 135 (15) | 2.59 (1.61–4.16) | 9 (9) | 0.78 (0.33–1.83) | npa | – |
Complete | 75 (29) | 485 (41) | 2.40 (1.71–3.37) | 421 (47) | 3.54 (2.48–5.03) | 15 (15) | 0.51 (0.26–1.00) | 21 (33) | – |
Age (mean, [SDb]) | 36 (8) | – | 1.05 (1.03–1.07) | – | 1.05 (1.03–1.07) | – | 1.03 (1.00–1.06) | – | – |
Aboriginal and/or Torres Strait Islander | 40 (16) | 129 (11) | 0.53 (0.34–0.83) | 92 (10) | 0.54 (0.33–0.86) | 10 (10) | 0.56 (0.24–1.27) | 12 (19) | – |
Self-reported fair or poor health | 75 (29) | 431 (36) | 1.61 (1.11–2.34) | 310 (35) | 1.59 (1.07–2.34) | 53 (51) | 1.91 (1.06–3.45) | 20 (31) | – |
GHQ-12 Score | 3 (1–6) | – | 0.97 (0.92–1.01) | – | 0.99 (0.94–1.04) | – | 0.96 (0.89–1.05) | – | – |
Area of residence | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Metro | 129 (51) | 628 (53) | REF | 478 (53) | REF | 52 (50) | REF | 36 (56) | – |
Regional | 84 (33) | 401 (34) | 0.99 (0.69–1.42) | 281 (31) | 0.94 (0.64–1.36) | 38 (37) | 1.14 (0.62–2.10) | 23 (36) | – |
Prison/other | 42 (16) | 159 (13) | 1.09 (0.68–1.77) | 135 (15) | 1.17 (0.71–1.93) | 13 (13) | 1.42 (0.58–3.47) | 5 (8) | – |
Main drug injected in the last 30Â days | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Heroin | 32 (13) | 137 (12) | REF | 101 (11) | REF | 5 (5) | REF | 14 (22) | – |
Methamphetamine | 72 (28) | 272 (23) | 1.92 (1.12–3.29) | 190 (21) | 1.72 (0.98–3.03) | 43 (42) | 4.59 (1.47–14.28) | 6 (9) | – |
Methamphetamine and Heroin | 53 (21) | 201 (17) | 1.66 (0.96–2.86) | 160 (18) | 1.66 (0.94–2.93) | 14 (14) | 2.37 (0.71–7.91) | 10 (16) | – |
No heroin or methamphetamine | 98 (38) | 578 (49) | 2.62 (1.58–4.36) | 443 (50) | 2.62 (1.53–4.46) | 41 (40) | 3.92 (1.28–11.96) | 34 (53) | – |
Self-reported lifetime chronic health condition | 170 (67) | 899 (76) | 1.19 (0.85–1.66) | 646 (72) | 0.91 (0.64–1.30) | 84 (82) | 1.93 (1.04–3.58) | 58 (91) | – |
Self-reported lifetime mental health condition | 213 (84) | 1053 (89) | 1.80 (1.16–2.79) | 789 (88) | 2.00 (1.25–3.21) | 90 (87) | 1.05 (0.50–2.18) | 56 (88) | – |
Times moved since last interview (median, [IQRc]) | 1 (0–3) | – | 0.85 (0.67–1.08) | – | 0.85 (0.66–1.09) | – | 0.95 (0.64–1.40) | – | – |
Self-reported unstable accommodation | 40 (16) | 234 (20) | 1.34 (0.79–2.29) | 183 (20) | 1.22 (0.70–2.12) | 33 (32) | 2.26 (0.98–5.20) | 11 (17) | – |
Current support worker | 72 (28) | 503 (42) | 1.88 (1.35–2.62) | 373 (42) | 2.06 (1.47–2.91) | 39 (38) | 1.52 (0.86–2.68) | 37 (58) | – |
Model constant | – | – | 0.00 (0.00–0.00) | – | 0.00 (0.00–0.00) |  | 0.00 (0.00–0.00) |  | – |
 | 10. ATC: Other (n = 127) | 11. Opioids (n = 125) | 12. Benzodiazepines (n = 353) | 13. Gabapentinoids (n = 114) | ||||
---|---|---|---|---|---|---|---|---|
n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | n (%) | AIRR (95%CI) | |
Post-release OAT use | Â | Â | Â | Â | Â | Â | Â | Â |
None | 90 (71) | REF | 80 (64) | REF | 74 (21) | REF | 28 (25) | REF |
Interrupted | 9 (7) | 0.70 (0.29–1.70) | 10 (8) | 0.89 (0.36–2.21) | 68 (19) | 4.99 (2.81–8.85) | 33 (29) | 6.78 (3.34–13.77) |
Complete | 28 (22) | 0.72 (0.39–1.33) | 35 (28) | 1.08 (0.57–2.06) | 211 (60) | 8.30 (5.28–13.04) | 53 (46) | 4.34 (2.37–7.94) |
Age (mean, [SDb]) | – | 1.09 (1.06–1.13) | – | 1.07 (1.03–1.10) | – | 1.06 (1.03–1.09) | – | 1.03 (0.99–1.07) |
Aboriginal and/or Torres Strait Islander | 15 (12) | 0.76 (0.34–1.67) | 8 (6) | 0.38 (0.14–1.05) | 36 (10) | 1.02 (0.55–1.88) | 14 (12) | 0.76 (0.33–1.71) |
Self-reported fair or poor health | 48 (38) | 1.18 (0.63–2.22) | 66 (53) | 3.11 (1.59–6.07) | 95 (27) | 1.55 (0.94–2.55) | 43 (38) | 1.41 (0.74–2.69) |
GHQ-12 Score | – | 0.92 (0.84–1.01) | - | 0.98 (0.90–1.06) | – | 0.95 (0.88–1.02) | – | 0.99 (0.91–1.07) |
Area of residence | Â | Â | Â | Â | Â | Â | Â | Â |
Metro | 62 (49) | REF | 81 (65) | REF | 178 (50) | REF | 71 (62) | REF |
Regional | 59 (46) | 1.24 (0.69–2.22) | 38 (30) | 0.77 (0.42–1.44) | 92 (26) | 0.97 (0.58–1.62) | 24 (21) | 0.56 (0.28–1.10) |
Prison/other | 6 (5) | 0.43 (0.15–1.20) | 6 (5) | 0.35 (0.11–1.10) | 83 (24) | 1.93 (1.02–3.66) | 19 (17) | 1.66 (0.75–3.67) |
Main drug injected in the last 30Â days | Â | Â | Â | Â | Â | Â | Â | Â |
Heroin | 17 (13) | REF | 27 (22) | REF | 47 (13) | REF | npa | – |
Methamphetamine | 33 (26) | 0.97 (0.39–2.39) | 23 (18) | 0.49 (0.21–1.17) | 83 (24) | 1.70 (0.81–3.59) | 12 (11) | – |
Methamphetamine and Heroin | 17 (13) | 0.81 (0.32–2.03) | 17 (14) | 0.50 (0.20–1.26) | 62 (18) | 1.28 (0.64–2.59) | 16 (14) | – |
No heroin or methamphetamine | 60 (47) | 1.31 (0.57–3.02) | 58 (46) | 1.05 (0.48–2.27) | 161 (46) | 1.53 (0.78–3.00) | 85 (75) | – |
Self-reported lifetime chronic health condition | 111 (87) | 2.51 (1.30–4.85) | 101 (81) | 1.88 (0.97–3.66) | 225 (64) | 0.77 (0.49–1.23) | 96 (84) | 1.85 (0.93–3.68) |
Self-reported lifetime mental health condition | 118 (93) | 3.47 (1.40–8.60) | 102 (82) | 1.15 (0.54–2.48) | 291 (82) | 1.58 (0.87–2.88) | 110 (96) | 5.12 (1.66–15.73) |
Times moved since last intervview (median, [IQRc]) | – | 0.88 (0.59–1.32) | – | 0.95 (0.63–1.44) | – | 1.10 (0.81–1.51) | – | 0.66 (0.43–1.02) |
Self-reported unstable accommodation | 7 (6) | 0.35 (0.12–1.02) | 9 (7) | 0.16 (0.05–0.50) | 91 (26) | 2.01 (1.00–4.04) | 32 (28) | 2.10 (0.88–5.02) |
Current support worker | 54 (43) | 1.08 (0.61–1.91) | 69 (55) | 3.98 (2.34–6.76) | 140 (40) | 1.96 (1.25–3.08) | 33 (29) | 1.03 (0.56–1.91) |
Model constant | – | 0.00 (0.00–0.00) | – | 0.00 (0.00–0.01) | – | 0.00 (0.00–0.00) | – | 0.00 (0.00–0.00) |